Report Overview
The Global External Ventricular Drain Market size is expected to be worth around USD 9.2 Billion by 2033 from USD 5.4 Billion in 2023, growing at a CAGR of 5.5% during the forecast period 2024 to 2033.
The rising prevalence of stroke and cerebral hemorrhage cases is anticipated to boost the market during the forecast period. In such cases, the external ventricular drain (EVD) is required for cerebrospinal fluid drainage and pressure monitoring. EVD helps in managing complications and improves patient outcomes. Some of the primary factors responsible for strokes and hemorrhages include high blood pressure, type 2 diabetes, high cholesterol, and road accidents. With the surge in number of diabetic and high-blood pressure patients in recent years, the market is likely to have substantial growth in the assessment period.
- As per the data updated by the Centers for Disease Control and Prevention in May 2024, approximately 38.4 million people of various age groups were suffering from diabetes in 2021. This equates to 11.6% of the total US population. The percentage of diabetic patients increased with old age, reaching 29.2% in people aged 65 years or above.
Key Takeaways
- Market Size:External Ventricular Drain Market size is expected to be worth around USD 9.2 Billion by 2033 from USD 5.4 Billion in 2023.
- Market Growth: The market growing at a CAGR of 5.5% during the forecast period 2024 to 2033.
- Product Analysis: The product segment is divided into ventricular drainage sets and accessories, with ventricular drainage sets taking the lead in 2023 with a market share of 80.7%.
- Application Analysis: Considering application, the market is divided into traumatic brain injury, hydrocephalus, subarachnoid hemorrhage, Reye syndrome, and others. Among these, traumatic brain injury held a significant share of 33.9%.
- End-Use Analysis: end-user segments segregated into hospitals, specialty clinics, ambulatory surgery centers, and others. Hospitals sector stands out as the dominant player, holding the largest revenue share of 65.6% in the external ventricular drain market.
- Type Analysis: The type segment is segregated into pediatric and adult, with the adult segment leading the market, holding a revenue share of 88.7%
- Regional Analysis: North America led the market by securing a market share of 36.1% in 2023.
By Product Analysis
The ventricular drainage sets segment led in 2023, claiming a market share of 80.7% owing to the high adoption of EVDs in neurocritical care. There has been a significant rise in the number of traumatic brain injuries and strokes in recent years. Increased knowledge about EVD advantages in neurosurgery and intensive care encourages its usage by specialists.
A rise in the usage of ventricular drainage sets in neurosurgery as a neurocritical care device boosts the demand for this product. As the population of developing countries increases, there is a need to expand healthcare facilities and make them more accessible, which also contributes to the growth of this segment.
By Application Analysis
Traumatic brain injury held a significant share of 33.9% due to the surge in the number of road accidents and falls. Patients with traumatic brain injuries call for the use of EVD in controlling intracranial pressure and CSF. New developments in neurocritical care and EVD technology are beneficial to patients which increases its utilization by neurosurgeons. The advancements in healthcare facilities and the availability of high-response trauma units in these facilities are expected to boost the growth of this segment.
By End-user Analysis
The hospitals segment had a tremendous growth rate, with a revenue share of 65.6% owing to the rising trend of using EVDs in neurosurgical and neurointensive care units. The increased number of neurosurgical operations is a major factor that influences the use of EVD in hospitals. The use is even higher when emergency departments and ICUs incorporate EVD in their practice for other procedures apart from neurosurgery.
Furthermore, factors such as increasing expenditure on the development of healthcare essential facilities and hospitalization of new-age technologies are expected to fuel the growth of this segment during the forecast period.
By Type Analysis
The adult segment grew at a substantial rate, generating a revenue portion of 88.7% due to the rising cases of stroke, cerebral hemorrhage, and traumatic brain injuries among adults. The growing incidence of age-related injuries in the geriatric demographic requires EVDs. The technological advancements in EVD and neurocritical care are enhancing patient’s prognosis, thus boosting the adoption of EVDs.
Adults including elderly people, being more prone to accidental head injuries and ailments such as hypertension and high blood pressure, are projected to be the dominant segment of this market.
Key Market Segments
By Product
- Ventricular Drainage Sets
- Accessories
By Application
- Traumatic Brain Injury
- Hydrocephalus
- Subarachnoid Hemorrhage
- Reye Syndrome
- Others
By End-user
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Others
By Type
- Pediatric
- Adult
Drivers
Growing Incidence Rate of Trauma and Cranial Injuries Worldwide
The surge in trauma and cranial injuries is expected to boost the market during the projection period, owing to the increasing demand for safe and effective treatment options. Traumatic brain injuries and cranial injuries often result in CSF accumulation, requiring EVDs for drainage and pressure monitoring. The rising number of accidents, falls, and violent crimes leads to high incidences of traumatic brain injuries (TBI), fueling the demand for EVDs.
Additionally, the advancements in emergency medical services and increased awareness of TBI treatment options significantly contribute to the growing adoption of EVDs.
- As per the World Health Organization, vehicle injuries are the ninth leading reason of death throughout the world. Crashes in road traffic cause 1.3 million deaths every year and around 20 to 50 million non-fatal injuries. The growth of these incidents is anticipated to propel the market.
Restraints
High Cost of EVDs
EVDs are complex medical devices requiring significant research, development, and manufacturing investments, leading to high production costs. These costs are passed on to healthcare providers and patients, often making EVDs inaccessible to the low- to middle-income group of people. This significantly limits the adoption of EVDs in resource-constrained healthcare settings, particularly in developing economies.
Opportunities
Increasing Demand for Noninvasive or Minimally Invasive Neurosurgeries
Growing demand for non- or minimally invasive neurosurgeries that help in reducing trauma and help deliver better outcomes for the patient is expected to impel the market during the forecast period. This makes the surgery highly cost-effective and safe, and there is a significant reduction in the recovery time as compared to the traditional procedure.
EVDs enable cerebrospinal fluid (CSF) drainage and pressure monitoring without requiring open surgery. It also allows for the precise control of CSF flow and pressure, reducing the risk of complications.
- As per the Defense & Veterans Brain Injury Center (DVBIC), about 414,000 traumatic brain injuries occurred in US service members between 2000 and 2019. Loud sound exposure in the form of blasts and shots is one of the main reasons for such injuries. The use of EVDs in minimally invasive surgeries proves crucial in the treatment of such patients.
Impact of Macroeconomic / Geopolitical Factors
Macroeconomic and geopolitical factors exert a significant influence on the external ventricular drain market, determining its growth trajectory. Macroeconomic factors such as economic growth and increased healthcare spending are expected to propel the EVD market forward.
Geopolitical factors such as global health initiatives and international collaborations are also expected to boost the demand. However, economic downturns, trade restrictions, and regulatory changes can hinder market growth.
Latest Trends
Growing use of temporary EVDs
Temporary EVDs are witnessing high usage as they facilitate minimally invasive solutions for problems such as intraventricular hemorrhage, hydrocephalus, and traumatic brain injuries that require ventricular decompression and cerebrospinal fluid drainage. More healthcare facilities are opting for temporary EVDs as they allow for quick cerebrospinal fluid (CSF) drainage for blockage or injury.
With the use of temporary external ventricular drains, multiple invasive surgeries are not required for ventricular catheter placement. This has made temporary EVDs a favored treatment option for situations requiring short-term CSF diversion.
- As per the report published by the World Health Organization in 2022, road accidents and falls are some of the leading reasons for traumatic brain injuries all across the world. These injuries require surgical intervention by using EVDs. According to the report, every year, more than 5 million people undergo traumatic brain injuries, and around 1 million patients need neurosurgical procedures.
Regional Analysis
North America is leading the external ventricular drain market
North America dominated the market with the highest revenue share of 36.1% owing to the high number of traumatic brain injuries and a growing prevalence of neurovascular disorders. According to the Centers for Disease Control and Prevention (CDC), the fifth primary cause of death in the US is stroke. It is estimated that more than 140,000 people are killed by cerebrovascular stroke every year.
The region has numerous med-tech companies that are engaged in neurosurgical catheter and drainage device manufacturing. Furthermore, a strong presence of advanced healthcare facilities and a high prevalence of neurological disorders such as Parkinson’s disease boost the market in the region.
The Middle East & Africa is expected to experience the highest CAGR during the forecast period
Middle East & Africa is projected to grow with the fastest CAGR due to the existence of a considerable patient base in the regional economies, coupled with high healthcare expenditures. Moreover, the growing number of road accidents in the Middle East & African region is surging at an alarming pace and is the main cause of death among young adults. This is anticipated to drive the regional market during the forecast period. According to the data from the World Health Organization, a road-traffic death rate of 26.6 deaths for every 100,000 people has been recorded in the African continent alone.
Key Regions and Countries
North America
- US
- Canada
Europe
- Germany
- France
- The UK
- Spain
- Italy
- Russia
- Netherland
- Rest of Europe
Asia Pacific
- China
- Japan
- South Korea
- India
- New Zealand
- Singapore
- Thailand
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Key Players Analysis
The major players in the external ventricular drain market are focused on the development of innovative medical devices and products, such as EVDs. The leading key players, such as Spiegelberg GmbH & Co. KG, Moller Medical GmbH, Medtronic, and Brain Navi Biotechnology Co., Ltd. implement strategic initiatives intended to enhance their competitive positioning.
Top Key Players
- Spiegelberg GmbH & Co. KG
- Sophysa
- Neuromedex GmbH
- Moller Medical GmbH
- Medtronic
- Integra LifeSciences
- Fuji Systems
- Brain Navi Biotechnology Co., Ltd.
- Braun SE
Recent Developments
- Sophysa (March 2024): Sophysa launched a new generation of programmable valves for hydrocephalus treatment. The new product, Sophysa Elite, features enhanced precision in cerebrospinal fluid (CSF) management and a user-friendly interface for neurosurgeons. The advanced valve system aims to improve patient outcomes and reduce complications associated with CSF drainage.
- Neuromedex GmbH (January 2024): Neuromedex GmbH announced a merger with a leading German medical device manufacturer, aiming to combine their expertise in neurosurgical products. This merger will enhance their product portfolio, particularly in external ventricular drainage systems, and expand their market reach globally. The merger is expected to drive innovation and improve the quality and availability of neurosurgical devices.
- Moller Medical GmbH (February 2024): Moller Medical GmbH introduced an upgraded version of their EVD kits with integrated anti-microbial properties. This development aims to reduce the risk of infections during external ventricular drainage procedures. The new kits have been well-received in clinical trials, demonstrating significant improvements in patient safety and infection control.
- Medtronic April 2024: Medtronic launched a cutting-edge EVD system, the Medtronic Precision Plus. This new product features advanced monitoring capabilities and compatibility with existing hospital infrastructure. The Precision Plus system is designed to provide more accurate intracranial pressure measurements and improve clinical outcomes for patients with severe brain injuries.